Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum

被引:27
作者
Iba, MM
Storch, A
Ghosal, A
Bennett, S
Reuhl, KR
Lowndes, HE
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, EOHSI, Piscataway, NJ 08854 USA
关键词
cytochrome P450 1A1 (CYP1A1); cytochrome P450 1A2 (CYP1A2); brain; cerebral cortex; cerebellum; beta-naphthoflavone; ethoxyresorufin O-deethylase (EROD); ethoxyresorufin O-demethylase (MROD);
D O I
10.1007/s00204-003-0488-1
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We examined the constitutive and inducible levels of microsomal cytochromes P450 1A1 and 1A2 (CYP1A) in rat cerebral cortex and cerebellum at the level of proteins by western blot analysis, and by catalytic activities via ethoxyresorufin O-deethylase (EROD) and methoxyresorufin O-demethylase (MROD). In the cerebral cortex, cytochrome P450 1A1 (CYP1A1) protein was more abundant than cytochrome P450 1A2 (CYP1A2) protein. Treatment with beta-naphthoflavone (beta-NF) caused a slight decrease in the level of the former but induced the latter 5.8-fold. In the cerebellum, in contrast to the cerebral cortex, CYP1A1 protein was less abundant than CYP1A2 protein in untreated rats, and while beta-NF treatment caused a 3.3-fold induction of CYP1A1 protein, it resulted in a 10-fold decrease in CYP1A2 protein. The CYP1A-preferential activity EROD was 2.3-fold higher in the cerebellum than in the cerebral cortex, and was induced 1.5-fold and 1.9-fold in the cerebellum and cerebral cortex, respectively, by beta-NF treatment. The CYP1A2-preferential activity MROD was 3-fold higher in the cerebellum than in the cerebral cortex, and was repressed 2.2-fold in the cerebellum but induced 3.7-fold in the cerebral cortex following beta-NF treatment. The results show that CYP1A1 and CYP1A2 proteins and catalytic activities are constitutively expressed in brain but are differentially inducible in the rat cerebral cortex and cerebellum.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 57 条
[1]  
[Anonymous], IARC SCI PUBL
[2]   EFFECT OF DIETARY AROCLOR-1254 EXPOSURE ON LUNG AND KIDNEY CYTOCHROMES P450 IN FEMALE RATS - EVIDENCE FOR P4501A2 EXPRESSION IN KIDNEY [J].
BEEBE, LE ;
FORNWALD, LW ;
ALWORTH, WL ;
DRAGNEV, KH ;
LUBET, RA .
CHEMICO-BIOLOGICAL INTERACTIONS, 1995, 97 (03) :215-227
[3]   Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria [J].
Bhagwat, SV ;
Boyd, MR ;
Ravindranath, V .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) :573-582
[4]  
CAI XM, 1998, P AM ASSOC CANC RES, V39, P2626
[5]   7-ethoxycoumarin deethylation activity in perfused isolated rat brain [J].
Chikaoka, Y ;
Tamura, M .
JOURNAL OF BIOCHEMISTRY, 1999, 125 (03) :634-640
[6]  
Chun YJ, 2001, CANCER RES, V61, P8164
[7]   Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens [J].
Crespi, CL ;
Penman, BW ;
Steimel, TD ;
Smith, T ;
Yang, CS ;
Sutter, TR .
MUTAGENESIS, 1997, 12 (02) :83-89
[8]   Bioflavonoids: selective substrates and inhibitors for cytochrome P450CYP1A and CYP1B1 [J].
Doostdar, H ;
Burke, MD ;
Mayer, RT .
TOXICOLOGY, 2000, 144 (1-3) :31-38
[9]   ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY [J].
EATON, DL ;
GALLAGHER, EP ;
BAMMLER, TK ;
KUNZE, KL .
PHARMACOGENETICS, 1995, 5 (05) :259-274
[10]  
Fang J, 2001, DRUG METAB DISPOS, V29, P1638